-
1
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos, M. H.; Lavedan, C.; Leroy, E.; Ide, S. E.; Dehejia, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; Boyer, R.; et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276, 2045-2047.
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
Ide, S.E.4
Dehejia, A.5
Dutra, A.6
Pike, B.7
Root, H.8
Rubenstein, J.9
Boyer, R.10
-
2
-
-
0032888789
-
Alpha-synuclein in Lewy body disease and alzheimer's disease
-
Hashimoto, M.; Masliah, E. Alpha-synuclein in Lewy body disease and alzheimer's disease. Brain Pathol. 1999, 9, 707-720.
-
(1999)
Brain Pathol
, vol.9
, pp. 707-720
-
-
Hashimoto, M.1
Masliah, E.2
-
3
-
-
0031762949
-
Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
-
Trojanowski, J. Q.; Goedert, M.; Iwatsubo, T.; Lee, V. M. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ. 1998, 5, 832-837.
-
(1998)
Cell Death Differ
, vol.5
, pp. 832-837
-
-
Trojanowski, J.Q.1
Goedert, M.2
Iwatsubo, T.3
Lee, V.M.4
-
4
-
-
2642514788
-
Alpha-synuclein: Normal function and role in neurodegenerative diseases
-
Norris, E. H.; Giasson, B. I.; Lee, V. M. Alpha-synuclein: Normal function and role in neurodegenerative diseases. Curr. Top. Dev. Biol. 2004, 60, 17-54.
-
(2004)
Curr. Top. Dev. Biol
, vol.60
, pp. 17-54
-
-
Norris, E.H.1
Giasson, B.I.2
Lee, V.M.3
-
5
-
-
84880229894
-
Parkinson's disease-The debate on the clinical phenomenology, aetiology, pathology and pathogenesis
-
Jenner, P.; Morris, H. R.; Robbins, T. W.; Goedert, M.; Hardy, J.; Ben-Shlomo, Y.; Bolam, P.; Burn, D.; Hindle, J. V.; Brooks, D. Parkinson's disease-The debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J. Parkinson's Dis. 2013, 3, 1-11.
-
(2013)
J. Parkinson's Dis
, vol.3
, pp. 1-11
-
-
Jenner, P.1
Morris, H.R.2
Robbins, T.W.3
Goedert, M.4
Hardy, J.5
Ben-Shlomo, Y.6
Bolam, P.7
Burn, D.8
Hindle, J.V.9
Brooks, D.10
-
6
-
-
84908617390
-
Role of genomics in translational research for Parkinson's disease
-
Sekiyama, K.; Takamatsu, Y.; Waragai, M.; Hashimoto, M. Role of genomics in translational research for Parkinson's disease. Biochem. Biophys. Res. Commun. 2014, 452, 226-235.
-
(2014)
Biochem. Biophys. Res. Commun
, vol.452
, pp. 226-235
-
-
Sekiyama, K.1
Takamatsu, Y.2
Waragai, M.3
Hashimoto, M.4
-
7
-
-
69549116777
-
Formation and development of Lewy pathology: A critical update
-
Jellinger, K. A. Formation and development of Lewy pathology: A critical update. J. Neurol. 2009, 256, 270-279.
-
(2009)
J. Neurol
, vol.256
, pp. 270-279
-
-
Jellinger, K.A.1
-
8
-
-
84879122389
-
The Lewy body in Parkinson's disease and related neurodegenerative disorders
-
Wakabayashi, K.; Tanji, K.; Odagiri, S.; Miki, Y.; Mori, F.; Takahashi, H. The Lewy body in Parkinson's disease and related neurodegenerative disorders. Mol. Neurobiol. 2013, 47, 495-508.
-
(2013)
Mol. Neurobiol
, vol.47
, pp. 495-508
-
-
Wakabayashi, K.1
Tanji, K.2
Odagiri, S.3
Miki, Y.4
Mori, F.5
Takahashi, H.6
-
9
-
-
80055034288
-
Alzheimer's prevention initiative: A plan to accelerate the evaluation of presymptomatic treatments
-
Reiman, E. M.; Langbaum, J. B.; Fleisher, A. S.; Caselli, R. J.; Chen, K.; Ayutyanont, N.; Quiroz, Y. T.; Kosik, K. S.; Lopera, F.; Tariot, P. N. Alzheimer's prevention initiative: A plan to accelerate the evaluation of presymptomatic treatments. J. Alzheimer's Dis. 2011, 26, 321-329.
-
(2011)
J. Alzheimer's Dis
, vol.26
, pp. 321-329
-
-
Reiman, E.M.1
Langbaum, J.B.2
Fleisher, A.S.3
Caselli, R.J.4
Chen, K.5
Ayutyanont, N.6
Quiroz, Y.T.7
Kosik, K.S.8
Lopera, F.9
Tariot, P.N.10
-
10
-
-
20044385920
-
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease
-
Stokin, G. B.; Lillo, C.; Falzone, T. L.; Brusch, R. G.; Rockenstein, E.; Mount, S. L.; Raman, R.; Davies, P.; Masliah, E.; Williams, D. S.; et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307, 1282-1288.
-
(2005)
Science
, vol.307
, pp. 1282-1288
-
-
Stokin, G.B.1
Lillo, C.2
Falzone, T.L.3
Brusch, R.G.4
Rockenstein, E.5
Mount, S.L.6
Raman, R.7
Davies, P.8
Masliah, E.9
Williams, D.S.10
-
11
-
-
84876727774
-
Toxic neurofilamentous axonopathies-Accumulation of neurofilaments and axonal degeneration
-
Llorens, J. Toxic neurofilamentous axonopathies-Accumulation of neurofilaments and axonal degeneration. J. Intern. Med. 2013, 273, 478-489.
-
(2013)
J. Intern. Med
, vol.273
, pp. 478-489
-
-
Llorens, J.1
-
12
-
-
84916890711
-
Membrane-shaping disorders: A common pathway in axon degeneration
-
Hubner, C. A.; Kurth, I. Membrane-shaping disorders: A common pathway in axon degeneration. Brain 2014, 137, 3109-3121.
-
(2014)
Brain
, vol.137
, pp. 3109-3121
-
-
Hubner, C.A.1
Kurth, I.2
-
13
-
-
84929659660
-
Toxic neuropathies: Mechanistic insights based on a chemical perspective
-
LoPachin, R. M.; Gavin, T. Toxic neuropathies: Mechanistic insights based on a chemical perspective. Neurosci. Lett. 2015, 596, 78-83.
-
(2015)
Neurosci. Lett
, vol.596
, pp. 78-83
-
-
LoPachin, R.M.1
Gavin, T.2
-
14
-
-
84876584556
-
Diversity of mitochondrial pathology in a mouse model of axonal degeneration in synucleinopathies
-
Sekigawa, A.; Takamatsu, Y.; Sekiyama, K.; Takenouchi, T.; Sugama, S.; Waragai, M.; Fujita, M.; Hashimoto, M. Diversity of mitochondrial pathology in a mouse model of axonal degeneration in synucleinopathies. Oxidative Med. Cell. Longev. 2013, doi: 10. 1155/2013/817807.
-
(2013)
Oxidative Med. Cell. Longev
-
-
Sekigawa, A.1
Takamatsu, Y.2
Sekiyama, K.3
Takenouchi, T.4
Sugama, S.5
Waragai, M.6
Fujita, M.7
Hashimoto, M.8
-
15
-
-
84873053822
-
Axon pathology in age-related neurodegenerative disorders
-
Adalbert, R.; Coleman, M. P. Axon pathology in age-related neurodegenerative disorders. Neuropathol. Appl. Neurobiol. 2012, doi: 10. 1111/j. 1365-2990. 2012. 01308. x.
-
(2012)
Neuropathol. Appl. Neurobiol
-
-
Adalbert, R.1
Coleman, M.P.2
-
16
-
-
32544442518
-
Gastric β-synuclein immunoreactive inclusions in meissner's and auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
-
Braak, H.; de Vos, R. A.; Bohl, J.; del Tredici, K. Gastric β-synuclein immunoreactive inclusions in meissner's and auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 2006, 396, 67-72.
-
(2006)
Neurosci. Lett
, vol.396
, pp. 67-72
-
-
Braak, H.1
de Vos, R.A.2
Bohl, J.3
del Tredici, K.4
-
17
-
-
5444255434
-
Stages in the development of Parkinson's disease-related pathology
-
Braak, H.; Ghebremedhin, E.; Rub, U.; Bratzke, H.; del Tredici, K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004, 318, 121-134.
-
(2004)
Cell Tissue Res
, vol.318
, pp. 121-134
-
-
Braak, H.1
Ghebremedhin, E.2
Rub, U.3
Bratzke, H.4
del Tredici, K.5
-
18
-
-
39749123263
-
Axonal β-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
-
Orimo, S.; Uchihara, T.; Nakamura, A.; Mori, F.; Kakita, A.; Wakabayashi, K.; Takahashi, H. Axonal β-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008, 131, 642-650.
-
(2008)
Brain
, vol.131
, pp. 642-650
-
-
Orimo, S.1
Uchihara, T.2
Nakamura, A.3
Mori, F.4
Kakita, A.5
Wakabayashi, K.6
Takahashi, H.7
-
19
-
-
0033897735
-
Neurodegeneration with brain iron accumulation, type 1 is characterized by and synuclein neuropathology
-
Galvin, J. E.; Giasson, B.; Hurtig, H. I.; Lee, V. M.; Trojanowski, J. Q. Neurodegeneration with brain iron accumulation, type 1 is characterized by and synuclein neuropathology. Am. J. Pathol. 2000, 157, 361-368.
-
(2000)
Am. J. Pathol
, vol.157
, pp. 361-368
-
-
Galvin, J.E.1
Giasson, B.2
Hurtig, H.I.3
Lee, V.M.4
Trojanowski, J.Q.5
-
20
-
-
0033539664
-
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein
-
Galvin, J. E.; Uryu, K.; Lee, V. M.; Trojanowski, J. Q. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. USA 1999, 96, 13450-13455.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 13450-13455
-
-
Galvin, J.E.1
Uryu, K.2
Lee, V.M.3
Trojanowski, J.Q.4
-
21
-
-
0037173006
-
Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice
-
Lee, M. K.; Stirling, W.; Xu, Y.; Xu, X.; Qui, D.; Mandir, A. S.; Dawson, T. M.; Copeland, N. G.; Jenkins, N. A.; Price, D. L. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. USA 2002, 99, 8968-8973.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 8968-8973
-
-
Lee, M.K.1
Stirling, W.2
Xu, Y.3
Xu, X.4
Qui, D.5
Mandir, A.S.6
Dawson, T.M.7
Copeland, N.G.8
Jenkins, N.A.9
Price, D.L.10
-
22
-
-
65449181204
-
β-Synucleinopathy: Neurodegeneration associated with overexpression of the mouse protein
-
Ninkina, N.; Peters, O.; Millership, S.; Salem, H.; van der Putten, H.; Buchman, V. L. β-Synucleinopathy: Neurodegeneration associated with overexpression of the mouse protein. Hum. Mol. Genet. 2009, 18, 1779-1794.
-
(2009)
Hum. Mol. Genet
, vol.18
, pp. 1779-1794
-
-
Ninkina, N.1
Peters, O.2
Millership, S.3
Salem, H.4
van der Putten, H.5
Buchman, V.L.6
-
23
-
-
78650066331
-
A beta-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain
-
Fujita, M.; Sugama, S.; Sekiyama, K.; Sekigawa, A.; Tsukui, T.; Nakai, M.; Waragai, M.; Takenouchi, T.; Takamatsu, Y.; Wei, J.; et al. A beta-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain. Nat. Commun. 2010, doi: 10. 1038/ncomms1101.
-
(2010)
Nat. Commun
-
-
Fujita, M.1
Sugama, S.2
Sekiyama, K.3
Sekigawa, A.4
Tsukui, T.5
Nakai, M.6
Waragai, M.7
Takenouchi, T.8
Takamatsu, Y.9
Wei, J.10
-
24
-
-
84866547908
-
Distinct mechanisms of axonal globule formation in mice expressing human wild type alpha-synuclein or dementia with Lewy bodies-linked p123h β-synuclein
-
Sekigawa, A.; Fujita, M.; Sekiyama, K.; Takamatsu, Y.; Rockenstein, E.; la Spada, A. R.; Masliah, E.; Hashimoto, M. Distinct mechanisms of axonal globule formation in mice expressing human wild type alpha-synuclein or dementia with Lewy bodies-linked p123h β-synuclein. Mol. Brain 2012, doi: 10. 1186/1756-6606-5-34.
-
(2012)
Mol. Brain
-
-
Sekigawa, A.1
Fujita, M.2
Sekiyama, K.3
Takamatsu, Y.4
Rockenstein, E.5
la Spada, A.R.6
Masliah, E.7
Hashimoto, M.8
-
25
-
-
41149155444
-
Alpha-synuclein pathology in the neostriatum in Parkinson's disease
-
Mori, F.; Tanji, K.; Zhang, H.; Kakita, A.; Takahashi, H.; Wakabayashi, K. Alpha-synuclein pathology in the neostriatum in Parkinson's disease. Acta Neuropathol. 2008, 115, 453-459.
-
(2008)
Acta Neuropathol
, vol.115
, pp. 453-459
-
-
Mori, F.1
Tanji, K.2
Zhang, H.3
Kakita, A.4
Takahashi, H.5
Wakabayashi, K.6
-
26
-
-
41949126259
-
Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: Analysis of human brain tissue
-
Hamano, K.; Hayashi, M.; Shioda, K.; Fukatsu, R.; Mizutani, S. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: Analysis of human brain tissue. Acta Neuropathol. 2008, 115, 547-559.
-
(2008)
Acta Neuropathol
, vol.115
, pp. 547-559
-
-
Hamano, K.1
Hayashi, M.2
Shioda, K.3
Fukatsu, R.4
Mizutani, S.5
-
27
-
-
26844531363
-
Maturation of autophagic vacuoles in mammalian cells
-
Eskelinen, E. L. Maturation of autophagic vacuoles in mammalian cells. Autophagy 2005, 1, 1-10.
-
(2005)
Autophagy
, vol.1
, pp. 1-10
-
-
Eskelinen, E.L.1
-
28
-
-
0017129274
-
Ultrastructural study of so-called curvilinear bodies and fingerprint structures in lymphocytes in late-infantile amaurotic idiocy
-
Stekhoven, J. H.; van Haelst, U. J. Ultrastructural study of so-called curvilinear bodies and fingerprint structures in lymphocytes in late-infantile amaurotic idiocy. Acta Neuropathol. 1976, 35, 295-306.
-
(1976)
Acta Neuropathol
, vol.35
, pp. 295-306
-
-
Stekhoven, J.H.1
van Haelst, U.J.2
-
29
-
-
84879143450
-
Gangliosides and gangliosidoses: Principles of molecular and metabolic pathogenesis
-
Sandhoff, K.; Harzer, K. Gangliosides and gangliosidoses: Principles of molecular and metabolic pathogenesis. J. Neurosci. 2013, 33, 10195-10208.
-
(2013)
J. Neurosci
, vol.33
, pp. 10195-10208
-
-
Sandhoff, K.1
Harzer, K.2
-
30
-
-
35348957237
-
Enhanced lysosomal pathology caused by β-synuclein mutants linked to dementia with Lewy bodies
-
Wei, J.; Fujita, M.; Nakai, M.; Waragai, M.; Watabe, K.; Akatsu, H.; Rockenstein, E.; Masliah, E.; Hashimoto, M. Enhanced lysosomal pathology caused by β-synuclein mutants linked to dementia with Lewy bodies. J. Biol. Chem. 2007, 282, 28904-28914.
-
(2007)
J. Biol. Chem
, vol.282
, pp. 28904-28914
-
-
Wei, J.1
Fujita, M.2
Nakai, M.3
Waragai, M.4
Watabe, K.5
Akatsu, H.6
Rockenstein, E.7
Masliah, E.8
Hashimoto, M.9
-
31
-
-
65649146849
-
Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies
-
Wei, J.; Fujita, M.; Nakai, M.; Waragai, M.; Sekigawa, A.; Sugama, S.; Takenouchi, T.; Masliah, E.; Hashimoto, M. Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies. Am. J. Pathol. 2009, 174, 1891-1909.
-
(2009)
Am. J. Pathol
, vol.174
, pp. 1891-1909
-
-
Wei, J.1
Fujita, M.2
Nakai, M.3
Waragai, M.4
Sekigawa, A.5
Sugama, S.6
Takenouchi, T.7
Masliah, E.8
Hashimoto, M.9
-
32
-
-
38349046973
-
Autophagy, amyloidogenesis and alzheimer disease
-
Nixon, R. A. Autophagy, amyloidogenesis and alzheimer disease. J. Cell Sci. 2007, 120, 4081-4091.
-
(2007)
J. Cell Sci
, vol.120
, pp. 4081-4091
-
-
Nixon, R.A.1
-
33
-
-
33748154216
-
Induction of autophagy in axonal dystrophy and degeneration
-
Wang, Q. J.; Ding, Y.; Kohtz, D. S.; Mizushima, N.; Cristea, I. M.; Rout, M. P.; Chait, B. T.; Zhong, Y.; Heintz, N.; Yue, Z. Induction of autophagy in axonal dystrophy and degeneration. J. Neurosci. 2006, 26, 8057-8068.
-
(2006)
J. Neurosci
, vol.26
, pp. 8057-8068
-
-
Wang, Q.J.1
Ding, Y.2
Kohtz, D.S.3
Mizushima, N.4
Cristea, I.M.5
Rout, M.P.6
Chait, B.T.7
Zhong, Y.8
Heintz, N.9
Yue, Z.10
-
34
-
-
82855181986
-
Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy
-
Lee, S.; Sato, Y.; Nixon, R. A. Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy. Autophagy 2011, 7, 1562-1563.
-
(2011)
Autophagy
, vol.7
, pp. 1562-1563
-
-
Lee, S.1
Sato, Y.2
Nixon, R.A.3
-
35
-
-
84869469287
-
Cellular and molecular mechanisms of mitochondrial function
-
Osellame, L. D.; Blacker, T. S.; Duchen, M. R. Cellular and molecular mechanisms of mitochondrial function. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26, 711-723.
-
(2012)
Best Pract. Res. Clin. Endocrinol. Metab
, vol.26
, pp. 711-723
-
-
Osellame, L.D.1
Blacker, T.S.2
Duchen, M.R.3
-
36
-
-
33646451063
-
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization
-
Bosco, D. A.; Fowler, D. M.; Zhang, Q.; Nieva, J.; Powers, E. T.; Wentworth, P., Jr.; Lerner, R. A.; Kelly, J. W. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2006, 2, 249-253.
-
(2006)
Nat. Chem. Biol
, vol.2
, pp. 249-253
-
-
Bosco, D.A.1
Fowler, D.M.2
Zhang, Q.3
Nieva, J.4
Powers, E.T.5
Wentworth, P.6
Lerner, R.A.7
Kelly, J.W.8
-
37
-
-
33751256567
-
The familial parkinsonism gene LRRK2 regulates neurite process morphology
-
MacLeod, D.; Dowman, J.; Hammond, R.; Leete, T.; Inoue, K.; Abeliovich, A. The familial parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006, 52, 587-593.
-
(2006)
Neuron
, vol.52
, pp. 587-593
-
-
McLeod, D.1
Dowman, J.2
Hammond, R.3
Leete, T.4
Inoue, K.5
Abeliovich, A.6
-
38
-
-
84863237380
-
Alpha-synuclein, LRRK2 and their interplay in Parkinson's disease
-
Liu, G.; Aliaga, L.; Cai, H. Alpha-synuclein, LRRK2 and their interplay in Parkinson's disease. Futur. Neurol. 2012, 7, 145-153.
-
(2012)
Futur. Neurol
, vol.7
, pp. 145-153
-
-
Liu, G.1
Aliaga, L.2
Cai, H.3
-
39
-
-
72149087091
-
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein
-
Lin, X.; Parisiadou, L.; Gu, X. L.; Wang, L.; Shim, H.; Sun, L.; Xie, C.; Long, C. X.; Yang, W. J.; Ding, J.; et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 2009, 64, 807-827.
-
(2009)
Neuron
, vol.64
, pp. 807-827
-
-
Lin, X.1
Parisiadou, L.2
Gu, X.L.3
Wang, L.4
Shim, H.5
Sun, L.6
Xie, C.7
Long, C.X.8
Yang, W.J.9
Ding, J.10
-
40
-
-
84868575932
-
Mitochondrial quality control mediated by PINK1 and Parkin: Links to parkinsonism
-
Narendra, D.; Walker, J. E.; Youle, R. Mitochondrial quality control mediated by PINK1 and Parkin: Links to parkinsonism. Cold Spring Harbor Perspect. Biol. 2012, doi: 10. 1101/cshperspect. a011338.
-
(2012)
Cold Spring Harbor Perspect. Biol
-
-
Narendra, D.1
Walker, J.E.2
Youle, R.3
-
41
-
-
0037023699
-
Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of alpha-synuclein assembly by α-and β-synucleins
-
Uversky, V. N.; Li, J.; Souillac, P.; Millett, I. S.; Doniach, S.; Jakes, R.; Goedert, M.; Fink, A. L. Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of alpha-synuclein assembly by α-and β-synucleins. J. Biol. Chem. 2002, 277, 11970-11978.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 11970-11978
-
-
Uversky, V.N.1
Li, J.2
Souillac, P.3
Millett, I.S.4
Doniach, S.5
Jakes, R.6
Goedert, M.7
Fink, A.L.8
-
42
-
-
0035950270
-
Beta-synuclein inhibits β-synuclein aggregation: A possible role as an anti-parkinsonian factor
-
Hashimoto, M.; Rockenstein, E.; Mante, M.; Mallory, M.; Masliah, E. Beta-synuclein inhibits β-synuclein aggregation: A possible role as an anti-parkinsonian factor. Neuron 2001, 32, 213-223.
-
(2001)
Neuron
, vol.32
, pp. 213-223
-
-
Hashimoto, M.1
Rockenstein, E.2
Mante, M.3
Mallory, M.4
Masliah, E.5
-
43
-
-
33749246152
-
Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression
-
Fan, Y.; Limprasert, P.; Murray, I. V.; Smith, A. C.; Lee, V. M.; Trojanowski, J. Q.; Sopher, B. L.; la Spada, A. R. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Hum. Mol. Genet. 2006, 15, 3002-3011.
-
(2006)
Hum. Mol. Genet
, vol.15
, pp. 3002-3011
-
-
Fan, Y.1
Limprasert, P.2
Murray, I.V.3
Smith, A.C.4
Lee, V.M.5
Trojanowski, J.Q.6
Sopher, B.L.7
la Spada, A.R.8
-
44
-
-
84858192847
-
Beta-synuclein in the pathogenesis of Parkinson's disease and related alpha-synucleinopathies: Emerging roles and new directions
-
Hashimoto, M.; la Spada, A. Beta-synuclein in the pathogenesis of Parkinson's disease and related alpha-synucleinopathies: Emerging roles and new directions. Futur. Neurol. 2012, 7, 155-163.
-
(2012)
Futur. Neurol
, vol.7
, pp. 155-163
-
-
Hashimoto, M.1
la Spada, A.2
-
45
-
-
9944244038
-
An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model
-
Hashimoto, M.; Rockenstein, E.; Mante, M.; Crews, L.; Bar-On, P.; Gage, F. H.; Marr, R.; Masliah, E. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther. 2004, 11, 1713-1723.
-
(2004)
Gene Ther
, vol.11
, pp. 1713-1723
-
-
Hashimoto, M.1
Rockenstein, E.2
Mante, M.3
Crews, L.4
Bar-On, P.5
Gage, F.H.6
Marr, R.7
Masliah, E.8
-
46
-
-
4644359042
-
β-Synuclein gene alterations in dementia with Lewy bodies
-
Ohtake, H.; Limprasert, P.; Fan, Y.; Onodera, O.; Kakita, A.; Takahashi, H.; Bonner, L. T.; Tsuang, D. W.; Murray, I. V.; Lee, V. M.; et al. β-Synuclein gene alterations in dementia with Lewy bodies. Neurology 2004, 63, 805-811.
-
(2004)
Neurology
, vol.63
, pp. 805-811
-
-
Ohtake, H.1
Limprasert, P.2
Fan, Y.3
Onodera, O.4
Kakita, A.5
Takahashi, H.6
Bonner, L.T.7
Tsuang, D.W.8
Murray, I.V.9
Lee, V.M.10
-
47
-
-
84883279162
-
β-Synuclein aggregates and induces neurodegeneration in dopaminergic neurons
-
Taschenberger, G.; Toloe, J.; Tereshchenko, J.; Akerboom, J.; Wales, P.; Benz, R.; Becker, S.; Outeiro, T.; Looger, L.; Bahr, M.; et al. β-Synuclein aggregates and induces neurodegeneration in dopaminergic neurons. Ann. Neurol. 2013, 74, 109-118.
-
(2013)
Ann. Neurol
, vol.74
, pp. 109-118
-
-
Taschenberger, G.1
Toloe, J.2
Tereshchenko, J.3
Akerboom, J.4
Wales, P.5
Benz, R.6
Becker, S.7
Outeiro, T.8
Looger, L.9
Bahr, M.10
-
48
-
-
21744444004
-
Forcing nonamyloidogenic beta-synuclein to fibrillate
-
Yamin, G.; Munishkina, L. A.; Karymov, M. A.; Lyubchenko, Y. L.; Uversky, V. N.; Fink, A. L. Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry 2005, 44, 9096-9107.
-
(2005)
Biochemistry
, vol.44
, pp. 9096-9107
-
-
Yamin, G.1
Munishkina, L.A.2
Karymov, M.A.3
Lyubchenko, Y.L.4
Uversky, V.N.5
Fink, A.L.6
-
49
-
-
0036670331
-
Development of a new treatment for alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides
-
Windisch, M.; Hutter-Paier, B.; Rockenstein, E.; Hashimoto, M.; Mallory, M.; Masliah, E. Development of a new treatment for alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides. J. Mol. Neurosci. 2002, 19, 63-69.
-
(2002)
J. Mol. Neurosci
, vol.19
, pp. 63-69
-
-
Windisch, M.1
Hutter-Paier, B.2
Rockenstein, E.3
Hashimoto, M.4
Mallory, M.5
Masliah, E.6
-
50
-
-
78649757873
-
Inhibiting β-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies
-
Shaltiel-Karyo, R.; Frenkel-Pinter, M.; Egoz-Matia, N.; Frydman-Marom, A.; Shalev, D. E.; Segal, D.; Gazit, E. Inhibiting β-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies. PLoS ONE 2010, 5, e13863.
-
(2010)
PLoS ONE
, vol.5
-
-
Shaltiel-Karyo, R.1
Frenkel-Pinter, M.2
Egoz-Matia, N.3
Frydman-Marom, A.4
Shalev, D.E.5
Segal, D.6
Gazit, E.7
-
51
-
-
84943200637
-
Disease-modifying effect of adiponectin in model of alpha-synucleinopathies
-
Sekiyama, K.; Waragai, M.; Akatsu, H.; Sugama, S.; Takenouchi, T.; Takamatsu, Y.; Fujita, M.; Sekigawa, A.; Rockenstein, E.; Inoue, S.; et al. Disease-modifying effect of adiponectin in model of alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 2014, 1, 479-489.
-
(2014)
Ann. Clin. Transl. Neurol
, vol.1
, pp. 479-489
-
-
Sekiyama, K.1
Waragai, M.2
Akatsu, H.3
Sugama, S.4
Takenouchi, T.5
Takamatsu, Y.6
Fujita, M.7
Sekigawa, A.8
Rockenstein, E.9
Inoue, S.10
-
52
-
-
0032191105
-
Filamentous nerve cell inclusions in neurodegenerative diseases
-
Goedert, M.; Spillantini, M. G.; Davies, S. W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 1998, 8, 619-632.
-
(1998)
Curr. Opin. Neurobiol
, vol.8
, pp. 619-632
-
-
Goedert, M.1
Spillantini, M.G.2
Davies, S.W.3
-
53
-
-
0023638714
-
The pathophysiology of proximal neurofilamentous giant axonal swellings: Implications for the pathogenesis of amyotrophic lateral sclerosis
-
Gold, B. G. The pathophysiology of proximal neurofilamentous giant axonal swellings: Implications for the pathogenesis of amyotrophic lateral sclerosis. Toxicology 1987, 46, 125-139.
-
(1987)
Toxicology
, vol.46
, pp. 125-139
-
-
Gold, B.G.1
-
54
-
-
0017107821
-
"Axonal spheroids" in the spinal cord of normal rabbits
-
Leonhardt, H. "Axonal spheroids" in the spinal cord of normal rabbits. Cell Tissue Res. 1976, 174, 99-108.
-
(1976)
Cell Tissue Res
, vol.174
, pp. 99-108
-
-
Leonhardt, H.1
|